INDUSTRY WATCH
THE INCIDENCE OF
CANCER WORLDWIDE IS
EXPECTED TO INCREASE
54% BY 2030, RESULTING
IN 22 MILLION NEW
DIAGNOSES ANNUALLY.
T
he incidence of cancer continues
to rise and strategic leveraging
of technology and big data will
be essential to addressing this global
healthcare challenge.
The incidence of cancer in the United
States is expected to increase 35%
over the next 14 years, resulting in 2.3
million new diagnoses by 2030 and
the incidence of cancer worldwide is
expected to increase 54% the same year,
resulting in 22 million new diagnoses
annually. The dynamic and evolving
landscape of cancer care provides a
model environment in which effective
harnessing of big data can drive
substantive improvements for patients,
clinicians, care centres and payers.
Current challenges in cancer care
Doing more with less is today’s top
mandate for the modern cancer centre.
Under constant pressure to cut costs and
improve quality of care, many oncology
centres face difficult decisions around
treatment paradigms and resource
utilisation while lacking a comprehensive
picture of the data that drives these
decisions. With increased specialisation
of care, patients undergoing treatment
for cancer see multiple providers,
frequently in multiple facilities.
This can complicate treatment and
lead to missed appointments and
tests. Additionally, many clinicians face
increased caseloads and may struggle to
co-ordinate care with other providers, all
while trying to ensure that their patients
receive optimum and timely treatment.
www.intelligentcio.com
Care centres also face a growing need to
improve the quality of care they deliver,
which requires understanding whether
deviations from these guidelines are due
to guideline improvements or medical
errors. As a result, there is an increasing
demand for enhanced decision support
capabilities that can transform millions
of data points into patient-specific,
evidence-based cancer care.
Additionally, basic access to quality
oncology care can be a major challenge
for patients in many emerging
economies. Increasing patient
throughput without compromising
the quality of care requires a versatile
solution that can improve the workflow,
safety and clinical decision making
that patients and physicians in these
emerging markets deserve.
Elekta’s MOSAIQ platform is
a powerful solution that
transforms big data into
actionable intelligence
MOSAIQ, Elekta’s industry-leading
comprehensive Oncology Information
System (OIS), is designed to improve
patient safety and clinical workflow by
housing all patient treatment-related
data in a single record that is both
centralised and multi-disciplinary. By
capturing and feeding data into MOSAIQ
Oncology Analytics (MOA), the MOSAIQ
solution produces a dynamic care plan
and operational analytics that help to
continually improve patient care, increase
efficiency and reduce costs. MOSAIQ can
help discover operational patterns and
trends and makes these data actionable
INTELLIGENTCIO
81